Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie Inc.
The US Food and Drug Administration (FDA) on Friday approved the sale of a packaged treatment called Viekira Pak made by AbbVie of North Chicago, Illinois. It includes a combination pill, which contains the antiviral drugs ombitasvir, paritaprevir and ritonavir, along with a tablet of dasabuvir.
All the ingredients are new except for ritonavir, which works to increase blood levels of paritaprevir.
It is among several new pill-only hepatitis C treatments that are big improvements on earlier treatments that are less effective, require injections and cause flu-like side effects.
For decades, hepatitis C carriers had no options but older treatments centered on injections of interferon, a synthetic version of an immune system protein that caused many of the nasty side effects.
Much more effective treatments with easier side effects have come on the market in the past several years, including three others approved by the FDA since November last year.
Those are Johnson & Johnson’s Olysio and Gilead Sciences’ Sovaldi and Harvoni.
The latter two have drawn considerable criticism from patients and doctors for their exorbitant price — Sovaldi costs about US$1,000 per pill or US$84,000 for a course of treatment — though their maker points out that successful treatment is cheaper than a liver transplant.
AbbVie said the shortest approved course of therapy for Viekira, 12 weeks, is set to cost about US$83,320 at wholesale prices. Patients and insurers have been hoping the growing competition would start to reduce the prices.
Viekira Pak was tested in six patient studies involving 2,308 participants with chronic hepatitis C, some of them with cirrhosis.
The tests showed 91 percent to 100 percent of the participants receiving the new combination had no detectable levels of the virus in their blood 12 weeks after treatment ended, indicating they had been cured.
Ryanair, Transavia, Volotea and other low-cost airlines are feeling the financial pain from high jet fuel prices as a result of the Middle East war and are cutting flights. The closure of the Strait of Hormuz has taken a huge chunk of oil supplies off the market, sending the price of jet fuel soaring and triggering fears of shortages that could force airlines to cancel flights. Airlines are not waiting for a lack of supplies to react. “Travel alert: Airlines are cutting thousands of flights right now,” Travel Therapy host Karen Schaler said in an Instagram reel this past weekend.
MANAGING RISKS: Taiwan has secured LNG sufficient to cover 95 percent of electricity demand for next month, UBS said, describing the government’s approach as proactive UBS Group AG has raised its forecast for Taiwan’s economic growth this year to 8 percent, up from 6.9 percent previously, and said expansion could reach as high as 8.6 percent if external energy shocks are avoided. The upgrade reflects a stronger-than-expected first-quarter performance and sustained momentum in artificial intelligence (AI)-driven exports, which UBS said are providing a firm foundation for growth despite geopolitical and energy risks. Taiwan’s GDP expanded 13.69 percent year-on-year in the first quarter, the fastest growth since the second quarter of 1987, the Directorate-General of Budget, Accounting and Statistics (DGBAS) reported on Thursday. On a seasonally
The list of Asian stocks that benefit from business partnership with Nvidia Corp is getting longer, as the region further integrates into the artificial intelligence (AI) chip giant’s business ecosystem. Just in the past week, South Korea’s LG Electronics Inc, Taiwan’s Nanya Technology Corp (南亞科技), as well as China’s Huizhou Desay SV Automotive Co (德賽西威) and Pateo Connect Technology Shanghai Corp (博泰車聯) have become the latest to rally on news of tie-ups, supply-chain participation or product collaboration with the US chip designer. Asian suppliers account for about 90 percent of Nvidia’s production costs, up from about 65 percent last year, data compiled
The Fair Trade Commission’s (FTC) ongoing review of Grab Holdings Ltd’s US$600 million acquisition of Foodpanda Taiwan’s operations, announced on March 23, has taken on fresh urgency as industry experts warn that the transaction could embed significant Chinese cybersecurity vulnerabilities into Taiwan’s digital infrastructure through Grab’s deep ties to autonomous-driving firm WeRide (文遠知行). Less than 16 months after the FTC blocked Uber Eats’ direct attempt to acquire Foodpanda Taiwan — citing potential combined market shares of 80 to 90 percent — the emergence of Grab as the buyer has prompted questions about whether the same competitive harm is simply being rerouted
RSS